Increased AUC w/ cyclosporin, teriflunomide, capmatinib, fostamatinib, febuxostat & darolutamide. Increased risk of myopathy & rhabdomyolysis w/ gemfibrozil, tafamidis & regorafenib; other lipid lowering therapies, cyclosporine; fenofibrates, niacin (≥ 1 g/day) & colchicine; simeprevir, dasabuvir/ombitasvir/paritaprevir/ritonavir, elbasvir/grazoprevir, sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, atazanavir/ritonavir, lopinavir/ritonavir & voxilaprevir. Decreased plasma conc w/ antacid susp containing Al & Mg hydroxide. Rise in INR w/ warfarin.